TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Vytrus says it has quantified two forms of plant-derived PDRN in its hair-care ingredients and reports findings from studies involving hair loss, scalp redness and curly-hair performance. The company presents the work as an extension of plant PDRN research it previously reported for skin care; the supplied report does not provide study sizes, methods or full results.
Plant biotechnology company Vytrus says it has quantified two forms of plant-derived PDRN in its hair-care actives and is reporting new findings on hair density, scalp redness and curly-hair performance. The results add hair and scalp applications to a portfolio the company has already presented for skin care, though the supplied report does not include study sizes or detailed methods for independent assessment.
Vytrus describes its approach as combining Phyto-PDRN, DNA fragments that it says act at the cell surface, with ExoPDRN™, PDRN naturally encapsulated within plant exosomes. The company says it has quantified both forms in its hair-care actives for the first time. It characterizes the two forms as complementary, but the source does not provide the quantities or an independent comparison of their effects.
One ingredient, Capilia Longa™, is made from Curcuma longa stem cells. Vytrus says the active is clinically proven to reduce hair loss and increase hair density. The report also notes that scientific literature associates PDRN with hair growth, but does not identify the studies or establish that this ingredient’s reported results arise specifically from PDRN.
For Elaya Renova™, derived from Mediterranean olive stem cells, Vytrus reports that ExoPDRN™ reduced scalp redness compared with placebo. The company also describes a new ex vivo study of curly hair: after one leave-on application, the study found improved hydration, less effort needed for combing, reduced frizz in high humidity and increased curl definition. The report does not state the sample size, test conditions beyond the humidity reference, or how large the changes were.
Plant PDRN Moves Into Hair Care
The report matters to cosmetic ingredient makers and product developers because it broadens the proposed uses of plant-derived PDRN beyond skin care to include hair fibers and the scalp. If the findings are supported by further evidence, the ingredients could give formulators a way to develop products aimed at several different concerns, including scalp comfort, hair density and curl management.
For consumers, the findings are not proof that a finished product will prevent hair loss or produce the same improvements seen in a laboratory or company study. Ingredient performance can depend on formulation and use, and the supplied report does not provide enough detail to compare the reported effects with established treatments or competing cosmetic ingredients. The claims should be read as company-reported research, not as a guarantee of results.
Products Worth Considering
Hyperice Normatec Elite Wireless Compression Boots Recovery – Standard Size
Therabody Theragun Mini 3rd Generation Massage Gun
Bowflex PR1000 Home Gym
As an affiliate, we earn on qualifying purchases.
Vytrus Extends Earlier Skin Research
The hair-care results build on plant-based PDRN studies Vytrus presented in April, according to the source article. Its skin-care portfolio includes Centella Reversa™, which combines Phyto-PDRN and ExoPDRN™ in a plant-cell secretome and is marketed for skin rejuvenation, regeneration and cellular DNA protection. The report also describes Sensia Carota™, which contains Phyto-PDRN and is intended to calm and protect sensitive skin and reduce redness.
The company’s broader proposal is a portfolio spanning skin, scalp and hair. That includes skin soothing and regeneration, scalp comfort, and hair-care claims relating to loss prevention, density and curls. The article presents these as Vytrus’s ingredient applications and reported research, rather than as findings from a single study testing the complete portfolio.
““Together, they form a dual-action strategy that works both at the cell surface and inside the cell.””
— Vytrus, describing its PDRN approach
Study Details Still Missing
The supplied report does not give the study sizes, full protocols, numerical results or publication details for the hair-care findings. It also does not specify how PDRN was quantified, provide the amounts found in each active, or explain whether the hair-loss and density claims were assessed in a controlled clinical trial. The report’s use of “clinically proven” for Capilia Longa™ is not accompanied by trial information that would let readers judge the evidence.
It is also unclear how the ex vivo curl findings translate to everyday use on people, whether benefits persist with repeated application, and how the ingredients perform in finished products. The reported reduction in scalp redness versus placebo is attributed to Vytrus, but the source offers no effect size or further information about the comparison. These gaps mean the claims cannot be independently evaluated from the material provided.
More Evidence Needed for Evaluation
The source article does not announce a publication date, regulatory decision or scheduled follow-up study. Vytrus is inviting formulators to request further information about its plant-based PDRN ingredients. The next useful evidence would include complete methods and results, including participant or sample counts, comparison conditions, measurement scales and whether the findings have been published or reviewed independently.
For now, the development is best understood as a company-reported expansion of its plant PDRN ingredient research into hair and scalp applications. Further study details will be needed to determine how robust the findings are and whether they apply to consumer products used outside controlled testing.
Key Questions
What did Vytrus report about plant PDRN?
Vytrus says it has quantified Phyto-PDRN and ExoPDRN™ in its hair-care actives and reported findings involving scalp redness and curly-hair performance.
Which hair and scalp ingredients are covered?
The report discusses Capilia Longa™, made from Curcuma longa stem cells, and Elaya Renova™, made from Mediterranean olive stem cells. Vytrus links them to hair-density and scalp or curl-care claims, respectively.
Are the reported results independently verified?
The supplied article attributes the findings to Vytrus and does not provide enough study information to assess them independently. It gives no study sizes, full methods or detailed numerical results.
Does the report show that plant PDRN prevents hair loss?
No. Vytrus describes Capilia Longa™ as clinically proven to reduce hair loss and increase hair density, but the source does not include the trial details needed to evaluate that claim. The report alone does not establish that plant PDRN prevents hair loss.
Source: rss
